HIGHLIGHTS
- who: Tian Tian from the Patients and tissue samples Two cohorts consisting of , primary DLBCL tissue samples were collected from patients treated at Fudan University Shanghai Cancer Center (FUSCC)All cases were diagnosed by two experienced pathologists (Yu and Li) independently in a blind manner according to the criteria of the World Health Organization classification of hematopoietic and lymphoid tissue. The inclusion criteria included available complete clinicopathological data, including age, sex, International Prognostic Index (IPI) scores, Ann Arbor stage, B symptoms, serum lactate dehydrogenase (LDH), and molecular type identified by immunohistochemistry (germinal center, cell like (GCB) versus . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.